Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teneligliptin vs Linagliptin in Type 2 Diabetes (TELIUS)
NCT03011177Phase 4Completed
- Sponsor
- Handok
- Start
- Jan 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of teneligliptin in type 2 diabetes mellitus (T2DM), sponsored by Handok. Started Jan 2017; status: completed.
02
Drugs
teneligliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03011177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03011177.